Unsuspected HIV-related lymphadenopathy in an aged couple

High eradication rates of Helicobacter pylori with a new sequential treatment.

Alimentary pharmacology & therapeutics·2003

Hodgkin disease developing in patients infected by human immunodeficiency virus results in clinical features and a prognosis similar to those in patients with human immunodeficiency virus-related non-Hodgkin lymphoma.

Cancer·2001

Secondary mutations in the protease region of human immunodeficiency virus and virologic failure in drug-naive patients treated with protease inhibitor-based therapy.

The Journal of infectious diseases·2001

The International Prognostic Index can be used as a guide to treatment decisions regarding patients with human immunodeficiency virus-related systemic non-Hodgkin lymphoma.

Cancer·1999

Tolerability of twice-weekly rifabutin-isoniazid combinations versus daily isoniazid for latent tuberculosis in HIV-infected subjects: a pilot study.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·1999

Effects of recombinant granulocyte colony-stimulating factor (G-CSF) in patients treated with ProMACE-CytaBOM for HIV-related non-Hodgkin's lymphoma (NHL).

Haematologica·1998

Cusatuzumab combined with venetoclax with or without azacitidine in unfit patients with newly diagnosed acute myeloid leukemia: phase Ib ELEVATE study.

Haematologica·2026

Surveying survival: benchmarking acute myeloid leukemia outcomes without transplant.

Haematologica·2026

Measurable residual KMT2A partial tandem duplication before allogeneic stem cell transplantation in acute myeloid leukemia.

Haematologica·2026

Normal platelet function in a patient with ARHGEF1 deficiency.

Haematologica·2026

Bone marrow biopsy characteristics at nadir after intensive induction therapy do not predict outcomes in adult acute myeloid leukemia patients: an analysis of ECOG-ACRIN clinical trials.

Haematologica·2026

Efficacy and safety of bridging therapy prior to CAR T-cell therapy in relapsed or refractory multiple myeloma.

Haematologica·2026

AA Challenge: An interactive French-language educational program on the causes of AA amyloidosis - Analysis of 2,597 responses to 12 clinical quizzes

Nephrologie & therapeutique·2026

Immune Checkpoint Inhibitor-Induced Pancreatitis.

United European gastroenterology journal·2026

Ovarian Teratoma After Treatment for Coexisting Anti-NMDA Receptor and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Encephalitis.

Journal of child neurology·2026

[From syndrome of inappropriate antidiuretic hormone secretion deficiency to excess - Challenges and solutions in a unique case].

Nutricion hospitalaria·2026

Identification of human leukocyte antigen class I risk alleles and enriched T cell receptor groups in activated T cell pediatric acute liver failure.

Journal of pediatric gastroenterology and nutrition·2026

The synergistic impact of granulocytic myeloid-derived suppressor cells and innate lymphoid cells in systemic sclerosis.

Arthritis & rheumatology (Hoboken, N.J.)·2026

Related Experiment Videos

Unsuspected HIV-related lymphadenopathy in an aged couple

Related Concept Videos

High eradication rates of Helicobacter pylori with a new sequential treatment.

Hodgkin disease developing in patients infected by human immunodeficiency virus results in clinical features and a prognosis similar to those in patients with human immunodeficiency virus-related non-Hodgkin lymphoma.

Secondary mutations in the protease region of human immunodeficiency virus and virologic failure in drug-naive patients treated with protease inhibitor-based therapy.

The International Prognostic Index can be used as a guide to treatment decisions regarding patients with human immunodeficiency virus-related systemic non-Hodgkin lymphoma.

Tolerability of twice-weekly rifabutin-isoniazid combinations versus daily isoniazid for latent tuberculosis in HIV-infected subjects: a pilot study.

Effects of recombinant granulocyte colony-stimulating factor (G-CSF) in patients treated with ProMACE-CytaBOM for HIV-related non-Hodgkin's lymphoma (NHL).

Cusatuzumab combined with venetoclax with or without azacitidine in unfit patients with newly diagnosed acute myeloid leukemia: phase Ib ELEVATE study.

Surveying survival: benchmarking acute myeloid leukemia outcomes without transplant.

Measurable residual KMT2A partial tandem duplication before allogeneic stem cell transplantation in acute myeloid leukemia.

Normal platelet function in a patient with ARHGEF1 deficiency.

Bone marrow biopsy characteristics at nadir after intensive induction therapy do not predict outcomes in adult acute myeloid leukemia patients: an analysis of ECOG-ACRIN clinical trials.

Efficacy and safety of bridging therapy prior to CAR T-cell therapy in relapsed or refractory multiple myeloma.

AA Challenge: An interactive French-language educational program on the causes of AA amyloidosis - Analysis of 2,597 responses to 12 clinical quizzes

Immune Checkpoint Inhibitor-Induced Pancreatitis.

Ovarian Teratoma After Treatment for Coexisting Anti-NMDA Receptor and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Encephalitis.

[From syndrome of inappropriate antidiuretic hormone secretion deficiency to excess - Challenges and solutions in a unique case].

Identification of human leukocyte antigen class I risk alleles and enriched T cell receptor groups in activated T cell pediatric acute liver failure.

The synergistic impact of granulocytic myeloid-derived suppressor cells and innate lymphoid cells in systemic sclerosis.

Related Experiment Videos

Unsuspected HIV-related lymphadenopathy in an aged couple

Related Concept Videos

Related Articles